Zuckerberg's philanthropic venture unveils AI world model for drug discovery

By Jaspreet Singh May 27 (Reuters) - Biohub, a philanthropic venture of Meta CEO Mark Zuckerberg and his wife, Dr. Priscilla ...

Biohub releases a world model of protein biology

Biohub today announced the release of a world model of protein biology: a scientific engine for prediction, design, and ...
GEN

Mechanistic Modeling Improves Drug Discovery Workflows and Speeds Therapeutic Development

This is the final episode in our three-part GENcast series, where we discuss the virtues of mechanistic modeling and how it can significantly impact critical decision-making points in the drug ...

SandboxAQ brings its drug discovery models to Claude — no PhD in computing required

Other venture-backed companies like Chai Discovery and Isomorphic Labs have raced to build better models. SandboxAQ is betting that the bigger obstacle is access, and that Claude solves it.
Drug Target Review

Why AI models need patient data to deliver in drug discovery

Despite rapid advances in AI, many drug discovery models still struggle to translate computational predictions into clinical ...
GEN

GENcast: Reducing Drug Discovery and Development Risk with Mechanistic Modeling

The drug discovery and development process can be an arduous endeavor. Manufacturers spend considerable resources and money chasing down potential candidate molecules to create a potential new ...
BioTechniques

AlphaFold computational modeling in drug discovery: the good, the bad and the AI

A new study has utilized AlphaFold machine-learning software to find potential targets in the Escherichia coli (E. coli) essential proteome for developing novel antibacterial drugs. Drug discovery is ...